Riderflex

David is a seasoned entrepreneur and a leader in the mental healthcare and psychedelic research domains. He is the CEO of Maya, a platform that provides real-world evidence for researchers, legislators, life sciences, and insurance payors in the field of mental healthcare. Additionally, David leads Unlimited Sciences, a psychedelic research nonprofit that uses data science to study underground and surface practices of psychedelic healing. In 2019, he was a campaign lead in the Denver Psilocybin Initiative, which helped Denver become the first US city to reform its psilocybin policy. Maya is a Colorado Public Benefit Corporation focused on advancing the field of psychedelic medicine. The company aims to safely and ethically scale the use of psychedelics by bridging the gap between academic research and real-world evidence from practitioners. Maya has developed a real-world data platform connecting providers, participants, and researchers, creating a knowledge base to inform safe and accessible psychedelic prac